Lilly to build $470m North Carolina facility, trumpets tax reform 23-Jan-2020 By Ben Hargreaves Lilly will begin construction of a parenteral products-focused facility this year, suggesting that 462 new jobs will be created.
Merck looks to CMOs to help ease vaccine supply bottleneck 20-Jan-2020 By Nick Taylor Merck enlists CMOs to help increase Gardasil manufacturing capacity in response to rising demand.
PharmaMar to supply Jazz with drug product under $1bn deal 16-Jan-2020 By Nick Taylor PharmaMar set to supply Jazz Pharmaceuticals with cancer drug from two sites under terms of $1bn deal.
Sterling expects further HPAPI demand, looks for buy-out opportunities 15-Jan-2020 By Vassia Barba Sterling continues expansion and lines up further acquisitions, as the HPAPI market continues to see increasing demand, a company executive says.
FDA places Innate cancer trial on partial clinical hold over CMO issue 14-Jan-2020 By Nick Taylor The US FDA puts Innate Pharma trial on partial clinical hold after learning of CMO problems.
3M set to sell biopharma-focused CDMO for $650m 23-Dec-2019 By Nick Taylor 3M agrees to sell drug delivery contract service unit to investment group Altaris Capital Partners.
Avid frames Halozyme setback as potential positive for CDMO business 19-Dec-2019 By Nick Taylor Avid Bioservices sees potential upside to clinical development setback at big customer Halozyme.
Sanofi to 'optimize' CMOs to drive down spending 18-Dec-2019 By Nick Taylor Sanofi plans “optimization of CMOs and suppliers” as new CEO targets €2bn in savings by 2022.
Antibe engages global CMO to support planned pain drug partnership 16-Dec-2019 By Nick Taylor Antibe tasks global CMO with providing a reliable supply of pain drug, ATB-346.
Amneal invests $340m in generics distributor 16-Dec-2019 By Vassia Barba Amneal announces acquisition of 65.1% majority interest of generics distributing company, AvKARE, boosting its presence in the generics and federal healthcare market.
Agilent sets sights on filling new nucleic acid plant by 2021 16-Dec-2019 By Nick Taylor Agilent looks to fill new nucleic acid capacity by end of 2020, eyes further expansions.
Ex-Covance CEO Ratliff takes over as head of AMRI 13-Dec-2019 By Nick Taylor Ex-Covance leader John Ratliff replaces Michael Mulhern as CEO of AMRI.
Novartis sets 2020 target for commercial readiness of cell therapy CMO 10-Dec-2019 By Nick Taylor Novartis aims to have its Japanese cell therapy CMO commercially ready in the second half of 2020.
CSafe launches temperature-controlled packaging for cell therapies 10-Dec-2019 By Vassia Barba CSafe expands its cold chain offering with a series of logistics services suitable for temperature-controlled shipping of biologics.
Almac granted $1m to develop low-cost API manufacturing method 09-Dec-2019 By Vassia Barba Under funding from Bill and Melinda Gates Foundation, Almac initiates work to develop biosynthetic routes for APIs to be used in world aid programs.
